BrainQ, non-invasive, very low intensity, BCI-based frequency dependent electromagnetic field tailored treatment for neuro recovery (BQ).

Informacje na temat projektu

BQ-Technology

Identyfikator umowy o grant: 828120

DOI

10.3030/828120

Projekt został zamknięty

Data podpisania przez KE 2 Sierpnia 2018

Data rozpoczęcia 1 Sierpnia 2018

Data zakończenia 30 Listopada 2018

Finansowanie w ramach

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Koszt całkowity

€ 71 429,00

Wkład UE

€ 50 000,00

Koordynowany przez

BRAINQ TECHNOLOGIES LTD
Israel

Periodic Reporting for period 1 - BQ-Technology (BrainQ, non-invasive, very low intensity, BCI-based frequency dependent electromagnetic field tailored treatment for neuro recovery (BQ).)

Okres sprawozdawczy: 2018-08-01 do 2018-11-30

Podsumowanie kontekstu i ogólnych celów projektu

BrainQ is on a mission to revolutionise how we treat and manage neurological disorders such as stroke and spinal cord injury (SCI) through Artificial Intelligence (AI).
In the EU alone, the total cost of stroke to healthcare providers in 2015 was €45 Billion , with 72% of this being for direct in-hospital care based on data provided by SAFE (Stroke Alliance for Europe) . SCI, on the other hand, has lower incidence rates however still generates a substantial economic burden.
The overall onbjectives of BrainQ are related to the development and clinical validation of the innovative device, the BQ 1.0. The Phase 1 projects objectives are related to the technical and busienss feasibility assessment of the project.

Prace wykonane od początku projektu do końca okresu sprawozdawczego oraz najważniejsze dotychczasowe rezultaty

During the project, BrainQ reviewed the current stage of development and updated the development plan for the BQ 1.0. Within the duration of the project, the Company has also engaged with leading research hospitals in Italy and Spain. Discussions with these key stake holders have helped BrainQ palnning the clinical validation work foreseen in Europe.
The Company improved their understanding of the EU market and of the regulations affecting the commercialsiation of the BQ 1.0 in Europe.

Innowacyjność oraz oczekiwany potencjalny wpływ (w tym dotychczasowe znaczenie społeczno-gospodarcze i szersze implikacje społeczne projektu)

The BQ 1.0 is an innovative Brain Computer Interface (BCI) - based device that provides a completely non-invasive treatment for a broad range of neurological conditions such as stroke, spinal cord injury (SCI), and traumatic brain injury (TBI). The development of the BQ 1.0 has brought BrainQ to create a large-scale data set of EEG motor tasks currently composed of over 100,000 motor tasks files. The device delivers an electromagnetic treatment that is expected to enhance motor function and overall rehabilitation outputs for thousands of patients suffering from neuro trauma with motor impairment.

BrainQ logo